UnknownPHASE2, PHASE3NCT04966234
A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection
Studying Aspergillosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bambino Gesù Hospital and Research Institute
- Principal Investigator
- Adilia Warris, ProfUniversity of Exeter
- Intervention
- Posaconazole 100 MG [Noxafil](drug)
- Enrollment
- 135 enrolled
- Eligibility
- 8-17 years · All sexes
- Timeline
- 2021 – 2023
Study locations (30)
- Motol University Hospital, Prague, Czechia
- Centre hospitalier universitaire Dijon Bourgogne, Bourgogne, France
- Centre hospitalier universitaire Grenoble Alpes, Grenoble, France
- Centre hospitalier universitaire de Montpellier, Montpellier, France
- Katholisches Klinikum Bochum gGMBH, Klinik für Kinder- und Jugendmedizin der Ruhr-Universität Bochum, St. Josef Hospital, Bochum, Germany
- Technische Universität Dresden, Universitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Kinder- und Jugendmedizin, Dresden, Germany
- Universitätsklinikum Essen,Pediatric Pulmonology and Cystic Fibrosis Center, Essen, Germany
- Medizinische Hochschule Hannover, Klinik für Pädiatrische Pneumologie, Allergologie und Neonatologie, Hanover, Germany
- Universitätsklinikum Jena, Klinik für Kinder- und Jugendmedizin, Pädiatrische Pneumologie/Allergologie/Mukoviszidose-Zentrum, Jena, Germany
- Cystic Fibrosis Department, "Agia Sofia" Children's Hospital, Athens, Greece
- Cystic Fibrosis Center, 3rd Paediatric Dept, Aristotle University of Thessaloniki, Thessaloniki, Greece
- Cork University Hospital, Cork, Ireland
- ASST Spedali Civili Paediatric department, Brescia, Italy
- IRCCS Istituto Giannina Gaslini, Genoa, Italy
- University of Parma Department of Medicine and Surgery, Parma, Italy
- +15 more locations on ClinicalTrials.gov
Collaborators
University of Exeter · Radboud University Medical Center · Consorzio per Valutazioni Biologiche e Farmacologiche
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04966234 on ClinicalTrials.govOther trials for Aspergillosis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07238114Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk FactorsUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGPHASE2NCT06794554Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment OptionsMundipharma Research Limited
- RECRUITINGNCT07313527PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic ValueUniversity Hospital, Strasbourg, France
- ACTIVE NOT RECRUITINGNCT06583512Treatment Duration of IPAPeking University People's Hospital
- RECRUITINGNCT06885905Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-beingImperial College London
- RECRUITINGNANCT06440915Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in ChildrenShanghai Children's Medical Center
- RECRUITINGPHASE3NCT06447402A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary AspergillosisPost Graduate Institute of Medical Education and Research, Chandigarh
- RECRUITINGPHASE2NCT05653193Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility StudyManchester University NHS Foundation Trust